Building strong bones: molecular regulation of the osteoblast lineage (original) (raw)

• Razzaque, M. S. The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis. Nature Rev. Endocrinol. 5, 611–619 (2009).
  CAS Google Scholar
• Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003).
  CAS PubMed Google Scholar
• Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836–841 (2003).
  CAS PubMed Google Scholar
• Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121 (2005).
  CAS PubMed Google Scholar
• Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12–CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988 (2006).
  CAS PubMed Google Scholar
• Ferron, M. et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296–308 (2010).
  CAS PubMed PubMed Central Google Scholar
• Fulzele, K. et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142, 309–319 (2010).
  CAS PubMed PubMed Central Google Scholar
• Oury, F. et al. Endocrine regulation of male fertility by the skeleton. Cell 144, 796–809 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hall, B. K. in Bone and Cartilage: Developmental Skeletal Biology 13–30 (Elsevier Academic Press, 2005).
  Google Scholar
• Dudley, H. R. & Spiro, D. The fine structure of bone cells. J. Biophys. Biochem. Cytol. 11, 627–649 (1961).
  CAS PubMed PubMed Central Google Scholar
• Pritchard, J. J. A cytological and histochemical study of bone and cartilage formation in the rat. J. Anat. 86, 259–277 (1952).
  CAS PubMed PubMed Central Google Scholar
• Owen, M. Cell population kinetics of an osteogenic tissue. I. J. Cell Biol. 19, 19–32 (1963).
  CAS PubMed PubMed Central Google Scholar
• Owen, M. & Macpherson, S. Cell population kinetics of an osteogenic tissue. II. J. Cell Biol. 19, 33–44 (1963).
  CAS PubMed PubMed Central Google Scholar
• Bonewald, L. F. The amazing osteocyte. J. Bone Miner. Res. 26, 229–238 (2011).
  CAS PubMed Google Scholar
• van Bezooijen, R. L. et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199, 805–814 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bellido, T. et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146, 4577–4583 (2005).
  CAS PubMed Google Scholar
• Robling, A. G. et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283, 5866–5875 (2008).
  CAS PubMed Google Scholar
• Keller, H. & Kneissel, M. SOST is a target gene for PTH in bone. Bone 37, 148–158 (2005).
  CAS PubMed Google Scholar
• Powell, W. F. Jr. et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21–32 (2011).
  CAS PubMed PubMed Central Google Scholar
• Krause, C. et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J. Biol. Chem. 285, 41614–41626 (2010).
  CAS PubMed PubMed Central Google Scholar
• Li, X. et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883–19887 (2005).
  CAS PubMed Google Scholar
• Semenov, M., Tamai, K. & He, X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770–26775 (2005).
  CAS PubMed Google Scholar
• Olsen, B. R., Reginato, A. M. & Wang, W. Bone development. Annu. Rev. Cell Dev. Biol. 16, 191–220 (2000).
  CAS PubMed Google Scholar
• Kronenberg, H. M. Developmental regulation of the growth plate. Nature 423, 332–336 (2003).
  CAS PubMed Google Scholar
• Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 19, 329–344 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bianco, P., Riminucci, M., Gronthos, S. & Robey, P. G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180–192 (2001).
  CAS PubMed Google Scholar
• Friedenstein, A. J. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol. Blood Transfus. 25, 19–29 (1980).
  CAS PubMed Google Scholar
• Owen, M. & Friedenstein, A. J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42–60 (1988).
  CAS PubMed Google Scholar
• Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
  CAS PubMed Google Scholar
• Kuznetsov, S. A. et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335–1347 (1997).
  CAS PubMed Google Scholar
• Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324–336 (2007).
  CAS PubMed Google Scholar
• Morikawa, S. et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206, 2483–2496 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bianco, P., Robey, P. G. & Simmons, P. J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313–319 (2008).
  CAS PubMed PubMed Central Google Scholar
• Nombela-Arrieta, C., Ritz, J. & Silberstein, L. E. The elusive nature and function of mesenchymal stem cells. Nature Rev. Mol. Cell Biol. 12, 126–131 (2011).
  CAS Google Scholar
• Pignolo, R. J. & Kassem, M. Circulating osteogenic cells: implications for injury, repair, and regeneration. J. Bone Miner. Res. 26, 1685–1693 (2011).
  CAS PubMed Google Scholar
• Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. & de Crombrugghe, B. Sox9 is required for cartilage formation. Nature Genet. 22, 85–89 (1999).
  CAS PubMed Google Scholar
• Bi, W. et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl Acad. Sci. USA 98, 6698–6703 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kist, R., Schrewe, H., Balling, R. & Scherer, G. Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis 32, 121–123 (2002).
  CAS PubMed Google Scholar
• Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. & de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813–2828 (2002).
  CAS PubMed PubMed Central Google Scholar
• Akiyama, H. et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl Acad. Sci. USA 102, 14665–14670 (2005).
  CAS PubMed Google Scholar
• Mori-Akiyama, Y., Akiyama, H., Rowitch, D. H. & de Crombrugghe, B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc. Natl Acad. Sci. USA 100, 9360–9365 (2003).
  CAS PubMed PubMed Central Google Scholar
• Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755–764 (1997).
  CAS PubMed Google Scholar
• Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
  CAS PubMed Google Scholar
• Mundlos, S. et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773–779 (1997).
  CAS PubMed Google Scholar
• Lee, B. et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genet. 16, 307–310 (1997).
  CAS PubMed Google Scholar
• Choi, J. Y. et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl Acad. Sci. USA 98, 8650–8655 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ducy, P. et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13, 1025–1036 (1999).
  CAS PubMed PubMed Central Google Scholar
• Nishikawa, K. et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 120, 3455–3465 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hong, J. H. et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074–1078 (2005).
  CAS PubMed Google Scholar
• Cui, C. B., Cooper, L. F., Yang, X., Karsenty, G. & Aukhil, I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 23, 1004–1013 (2003).
  CAS PubMed PubMed Central Google Scholar
• Dobreva, G. et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971–986 (2006).
  CAS PubMed Google Scholar
• Satokata, I. et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nature Genet. 24, 391–395 (2000).
  CAS PubMed Google Scholar
• Tribioli, C. & Lufkin, T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126, 5699–5711 (1999).
  CAS PubMed Google Scholar
• Thomas, D. M. et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303–316 (2001).
  CAS PubMed Google Scholar
• Calo, E. et al. Rb regulates fate choice and lineage commitment in vivo. Nature 466, 1110–1114 (2010).
  PubMed PubMed Central Google Scholar
• Shimoyama, A. et al. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol. Biol. Cell 18, 2411–2418 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lee, M. H. et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J. Biol. Chem. 280, 35579–35587 (2005).
  CAS PubMed Google Scholar
• Robledo, R. F., Rajan, L., Li, X. & Lufkin, T. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev. 16, 1089–1101 (2002).
  CAS PubMed PubMed Central Google Scholar
• Bialek, P. et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 6, 423–435 (2004).
  CAS PubMed Google Scholar
• Funato, N. et al. Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2. Development 136, 615–625 (2009).
  CAS PubMed Google Scholar
• Kim, S. et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 17, 1979–1991 (2003).
  CAS PubMed PubMed Central Google Scholar
• Jones, D. C. et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223–1227 (2006).
  CAS PubMed Google Scholar
• Hesse, E. et al. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 191, 1271–1283 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kanzler, B., Kuschert, S. J., Liu, Y. H. & Mallo, M. Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area. Development 125, 2587–2597 (1998).
  CAS PubMed Google Scholar
• Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270–274 (2005).
  CAS PubMed Google Scholar
• Hilton, M. J. et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nature Med. 14, 306–314 (2008).
  CAS PubMed Google Scholar
• Ohba, S. et al. Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. Dev. Cell 14, 689–699 (2008).
  CAS PubMed Google Scholar
• Vega, R. B. et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555–566 (2004).
  CAS PubMed Google Scholar
• Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29 (2002).
  CAS PubMed Google Scholar
• Zhou, X. et al. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl Acad. Sci. USA 107, 12919–12924 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115–125 (2006).
  CAS PubMed PubMed Central Google Scholar
• Koga, T. et al. NFAT and Osterix cooperatively regulate bone formation. Nature Med. 11, 880–885 (2005).
  CAS PubMed Google Scholar
• Winslow, M. M. et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771–782 (2006).
  CAS PubMed Google Scholar
• Yu, V. W. et al. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169, 591–601 (2005).
  CAS PubMed PubMed Central Google Scholar
• Yang, X. et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin–Lowry Syndrome. Cell 117, 387–398 (2004).
  CAS PubMed Google Scholar
• Elefteriou, F. et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 4, 441–451 (2006).
  CAS PubMed PubMed Central Google Scholar
• Elefteriou, F. et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514–520 (2005).
  CAS PubMed Google Scholar
• Ambrogini, E. et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 11, 136–146 (2010).
  CAS PubMed PubMed Central Google Scholar
• Rached, M. T. et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11, 147–160 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wang, W. et al. Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development 136, 4143–4153 (2009).
  CAS PubMed PubMed Central Google Scholar
• Eferl, R. et al. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789–2799 (2004).
  CAS PubMed PubMed Central Google Scholar
• Jochum, W. et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nature Med. 6, 980–984 (2000).
  CAS PubMed Google Scholar
• Kveiborg, M. et al. ΔFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol. Cell. Biol. 24, 2820–2830 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sabatakos, G. et al. Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nature Med. 6, 985–990 (2000).
  CAS PubMed Google Scholar
• Kenner, L. et al. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164, 613–623 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ingham, P. W. & McMahon, A. P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059–3087 (2001).
  CAS PubMed Google Scholar
• Mo, R. et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124, 113–123 (1997).
  CAS PubMed Google Scholar
• Bai, C. B., Auerbach, W., Lee, J. S., Stephen, D. & Joyner, A. L. Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129, 4753–4761 (2002).
  CAS PubMed Google Scholar
• St-Jacques, B., Hammerschmidt, M. & McMahon, A. P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072–2086 (1999).
  CAS PubMed PubMed Central Google Scholar
• Long, F. et al. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131, 1309–1318 (2004).
  CAS PubMed Google Scholar
• Tu, X., Joeng, K. S. & Long, F. Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev. Biol. 1 Dec 2011 (doi:10.1016/j.ydbio.2011.11.013).
  CAS PubMed Google Scholar
• Joeng, K. S. & Long, F. The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 136, 4177–4185 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hilton, M. J., Tu, X., Cook, J., Hu, H. & Long, F. Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development 132, 4339–4351 (2005).
  CAS PubMed Google Scholar
• Maeda, Y. et al. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc. Natl Acad. Sci. USA 104, 6382–6387 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kimura, H., Ng, J. M. & Curran, T. Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13, 249–260 (2008).
  CAS PubMed Google Scholar
• Mak, K. K. et al. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev. Cell 14, 674–688 (2008).
  CAS PubMed Google Scholar
• Kopan, R. & Goate, A. A common enzyme connects notch signaling and Alzheimer's disease. Genes Dev. 14, 2799–2806 (2000).
  CAS PubMed Google Scholar
• Donoviel, D. B. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801–2810 (1999).
  CAS PubMed PubMed Central Google Scholar
• Herreman, A. et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11872–11877 (1999).
  CAS PubMed PubMed Central Google Scholar
• Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382–386 (1998).
  CAS PubMed Google Scholar
• Honjo, T. The shortest path from the surface to the nucleus: RBP-Jκ/Su(H) transcription factor. Genes Cells 1, 1–9 (1996).
  CAS PubMed Google Scholar
• Mohamed, S. A. et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem. Biophys. Res. Commun. 345, 1460–1465 (2006).
  CAS PubMed Google Scholar
• Simpson, M. A. et al. Mutations in NOTCH2 cause Hajdu–Cheney syndrome, a disorder of severe and progressive bone loss. Nature Genet. 43, 303–305 (2011).
  CAS PubMed Google Scholar
• Isidor, B. et al. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nature Genet. 43, 306–308 (2011).
  CAS PubMed Google Scholar
• Salie, R. et al. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone. Bone 46, 680–694 (2010).
  CAS PubMed Google Scholar
• Zanotti, S. et al. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 149, 3890–3899 (2008).
  CAS PubMed PubMed Central Google Scholar
• Engin, F. et al. Dimorphic effects of Notch signaling in bone homeostasis. Nature Med. 14, 299–305 (2008).
  CAS PubMed Google Scholar
• Tao, J. et al. Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J. Bone Miner. Res. 25, 2175–2183 (2010).
  CAS PubMed PubMed Central Google Scholar
• Engin, F. et al. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum. Mol. Genet. 18, 1464–1470 (2009).
  CAS PubMed PubMed Central Google Scholar
• Huelsken, J. & Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547–553 (2001).
  CAS PubMed Google Scholar
• Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell 5, 367–377 (2003).
  CAS PubMed Google Scholar
• Wu, X. et al. Rac1 activation controls nuclear localization of β-catenin during canonical Wnt signaling. Cell 133, 340–353 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513–523 (2001).
  CAS PubMed Google Scholar
• Boyden, L. M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513–1521 (2002).
  CAS PubMed Google Scholar
• Little, R. D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11–19 (2002).
  CAS PubMed Google Scholar
• Ai, M., Holmen, S. L., Van Hul, W., Williams, B. O. & Warman, M. L. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25, 4946–4955 (2005).
  CAS PubMed PubMed Central Google Scholar
• Semenov, M. V. & He, X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281, 38276–38284 (2006).
  CAS PubMed Google Scholar
• Ellies, D. L. et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J. Bone Miner. Res. 21, 1738–1749 (2006).
  CAS PubMed Google Scholar
• Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537–543 (2001).
  CAS PubMed Google Scholar
• Balemans, W. et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91–97 (2002).
  CAS PubMed PubMed Central Google Scholar
• Brunkow, M. E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577–589 (2001).
  CAS PubMed PubMed Central Google Scholar
• Staehling-Hampton, K. et al. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am. J. Med. Genet. 110, 144–152 (2002).
  PubMed Google Scholar
• Kato, M. et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303–314 (2002).
  CAS PubMed PubMed Central Google Scholar
• Bennett, C. N. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl Acad. Sci. USA 102, 3324–3329 (2005).
  CAS PubMed PubMed Central Google Scholar
• Holmen, S. L. et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19, 2033–2040 (2004).
  CAS PubMed Google Scholar
• Cui, Y. et al. Lrp5 functions in bone to regulate bone mass. Nature Med. 17, 684–691 (2011).
  CAS PubMed Google Scholar
• Yadav, V. K. et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825–837 (2008).
  CAS PubMed PubMed Central Google Scholar
• Glass, D. A., 2nd. et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751–764 (2005).
  CAS PubMed Google Scholar
• Holmen, S. L. et al. Essential role of β-catenin in postnatal bone acquisition. J. Biol. Chem. 280, 21162–21168 (2005).
  CAS PubMed Google Scholar
• Yadav, V. K., Arantes, H. P., Barros, E. R., Lazaretti-Castro, M. & Ducy, P. Genetic analysis of Lrp5 function in osteoblast progenitors. Calcif. Tissue Int. 86, 382–388 (2010).
  CAS PubMed Google Scholar
• Frost, M. et al. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J. Bone Miner. Res. 26, 1721–1728 (2011).
  CAS PubMed Google Scholar
• Yadav, V. K. et al. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nature Med. 16, 308–312 (2010).
  CAS PubMed Google Scholar
• Inose, H. et al. Efficacy of serotonin inhibition in mouse models of bone loss. J. Bone Miner. Res. 26, 2002–2011 (2011).
  CAS PubMed Google Scholar
• Hu, H. et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49–60 (2005).
  CAS PubMed Google Scholar
• Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231–3244 (2006).
  CAS PubMed Google Scholar
• Day, T. F., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739–750 (2005).
  CAS PubMed Google Scholar
• Hill, T. P., Spater, D., Taketo, M. M., Birchmeier, W. & Hartmann, C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727–738 (2005).
  CAS PubMed Google Scholar
• Joeng, K. S., Schumacher, C. A., Zylstra-Diegel, C. R., Long, F. & Williams, B. O. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev. Biol. 359, 222–229 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mak, K. K., Chen, M. H., Day, T. F., Chuang, P. T. & Yang, Y. Wnt/β-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133, 3695–3707 (2006).
  CAS PubMed Google Scholar
• Tu, X. et al. Noncanonical Wnt signaling through G protein-linked PKCδ activation promotes bone formation. Dev. Cell 12, 113–127 (2007).
  CAS PubMed PubMed Central Google Scholar
• Takada, I. et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation. Nature Cell Biol. 9, 1273–1285 (2007).
  CAS PubMed Google Scholar
• Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950–953 (2000).
  CAS PubMed Google Scholar
• Albers, J. et al. Control of bone formation by the serpentine receptor Frizzled-9. J. Cell Biol. 192, 1057–1072 (2011).
  CAS PubMed PubMed Central Google Scholar
• Feng, X. H. & Derynck, R. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659–693 (2005).
  CAS PubMed Google Scholar
• Bandyopadhyay, A. et al. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2, e216 (2006).
  PubMed PubMed Central Google Scholar
• Tsuji, K. et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nature Genet. 38, 1424–1429 (2006).
  CAS PubMed Google Scholar
• Kamiya, N. et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 135, 3801–3811 (2008).
  CAS PubMed Google Scholar
• Kamiya, N. et al. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J. Bone Miner. Res. 23, 2007–2017 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kamiya, N. et al. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J. Bone Miner. Res. 25, 200–210 (2010).
  CAS PubMed Google Scholar
• Mishina, Y. et al. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem. 279, 27560–27566 (2004).
  CAS PubMed Google Scholar
• Devlin, R. D. et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144, 1972–1978 (2003).
  CAS PubMed Google Scholar
• Tan, X. et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci. 120, 2162–2170 (2007).
  CAS PubMed Google Scholar
• Daluiski, A. et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nature Genet. 27, 84–88 (2001).
  CAS PubMed Google Scholar
• Kokabu, S. et al. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 10 Nov 2011 (doi:10.1210/me.2011-1168).
  CAS PubMed Google Scholar
• Itoh, N. & Ornitz, D. M. Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 237, 18–27 (2008).
  CAS PubMed Google Scholar
• Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139–149 (2005).
  CAS PubMed Google Scholar
• Ornitz, D. M. & Marie, P. J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446–1465 (2002).
  CAS PubMed Google Scholar
• Montero, A. et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105, 1085–1093 (2000).
  CAS PubMed PubMed Central Google Scholar
• Liu, Z., Lavine, K. J., Hung., I. H. & Ornitz, D. M. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev. Biol. 302, 80–91 (2007).
  CAS PubMed Google Scholar
• Ohbayashi, N. et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870–879 (2002).
  CAS PubMed PubMed Central Google Scholar
• Jacob, A. L., Smith, C., Partanen, J. & Ornitz, D. M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. 296, 315–328 (2006).
  CAS PubMed PubMed Central Google Scholar
• Yu, K. et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063–3074 (2003).
  CAS PubMed Google Scholar
• Eswarakumar, V. P. et al. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129, 3783–3793 (2002).
  CAS PubMed Google Scholar
• Eswarakumar, V. P., Horowitz, M. C., Locklin, R., Morriss-Kay, G. M. & Lonai, P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl Acad. Sci. USA 101, 12555–12560 (2004).
  CAS PubMed PubMed Central Google Scholar
• Valverde-Franco, G. et al. Defective bone mineralization and osteopenia in young adult FGFR3−/− mice. Hum. Mol. Genet. 13, 271–284 (2004).
  CAS PubMed Google Scholar
• Liu, F., Malaval, L. & Aubin, J. E. The mature osteoblast phenotype is characterized by extensive plasticity. Exp. Cell Res. 232, 97–105 (1997).
  CAS PubMed Google Scholar
• Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197–207 (2000).
  CAS PubMed Google Scholar
• Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305–317 (2002).
  CAS PubMed Google Scholar
• Yadav, V. K. et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138, 976–989 (2009).
  CAS PubMed PubMed Central Google Scholar
• Williams, G. A. et al. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J. Bone Miner. Res. 26, 1698–1709 (2011).
  CAS PubMed Google Scholar
• Thomas, T. et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630–1638 (1999).
  CAS PubMed Google Scholar
• Cornish, J. et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175, 405–415 (2002).
  CAS PubMed Google Scholar
• Shi, Y. et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl Acad. Sci. USA 105, 20529–20533 (2008).
  CAS PubMed PubMed Central Google Scholar
• Nissenson, R. A. & Juppner, H. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (ed. Rosen, C. J.) (Wiley, 2008).
  Google Scholar
• Tam, C. S., Heersche, J. N., Murray, T. M. & Parsons, J. A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110, 506–512 (1982).
  CAS PubMed Google Scholar
• Yakar, S. et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol. 189, 289–299 (2006).
  CAS PubMed Google Scholar
• Guo, J. et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 11, 161–171 (2010).
  CAS PubMed PubMed Central Google Scholar
• Black, D. M. et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349, 1207–1215 (2003).
  CAS PubMed Google Scholar
• Wu, X. et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7, 571–580 (2010).
  CAS PubMed PubMed Central Google Scholar
• Tang, Y. et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nature Med. 15, 757–765 (2009).
  CAS PubMed Google Scholar
• Giustina, A., Mazziotti, G. & Canalis, E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008).
  CAS PubMed PubMed Central Google Scholar
• DiGirolamo, D. J. et al. Mode of growth hormone action in osteoblasts. J. Biol. Chem. 282, 31666–31674 (2007).
  CAS PubMed Google Scholar
• Zhang, M. et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277, 44005–44012 (2002).
  CAS PubMed Google Scholar
• Zhao, G. et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141, 2674–2682 (2000).
  CAS PubMed Google Scholar
• Kawano, H. et al. Suppressive function of androgen receptor in bone resorption. Proc. Natl Acad. Sci. USA 100, 9416–9421 (2003).
  CAS PubMed PubMed Central Google Scholar
• Venken, K. et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21, 576–585 (2006).
  CAS PubMed Google Scholar
• Sims, N. A. et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J. Clin. Invest. 111, 1319–1327 (2003).
  CAS PubMed PubMed Central Google Scholar
• Vidal, O. et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl Acad. Sci. USA 97, 5474–5479 (2000).
  CAS PubMed PubMed Central Google Scholar
• Syed, F. A., Fraser, D. G., Monroe, D. G. & Khosla, S. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor α on bone. Bone 49, 208–216 (2011).
  CAS PubMed PubMed Central Google Scholar